|
|
Volumn 88, Issue 5, 2001, Pages 482-487
|
|
An anti-CD11/CD18 monoclonal antibody in patients with acute myocardial infarction having percutaneous transluminal coronary angioplasty (the FESTIVAL study)
a
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ACETYLSALICYLIC ACID;
CD11 ANTIGEN;
CD18 ANTIGEN;
HEPARIN;
MONOCLONAL ANTIBODY;
PLACEBO;
ROVELIZUMAB;
UNCLASSIFIED DRUG;
ACUTE HEART INFARCTION;
ADULT;
AGED;
ARTICLE;
BLOOD LEVEL;
CLINICAL FEATURE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DIAGNOSTIC IMAGING;
DIAGNOSTIC VALUE;
DOSE RESPONSE;
DOUBLE BLIND PROCEDURE;
DRUG SAFETY;
DRUG TOLERABILITY;
HEADACHE;
HUMAN;
LEUKOCYTOSIS;
MAJOR CLINICAL STUDY;
MALE;
MULTICENTER STUDY;
NAUSEA;
NEURALGIA;
PHASE 1 CLINICAL TRIAL;
PHYSICAL EXAMINATION;
PNEUMONIA;
PRIORITY JOURNAL;
RACE DIFFERENCE;
RANDOMIZED CONTROLLED TRIAL;
SEPSIS;
SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;
STATISTICAL ANALYSIS;
TRANSLUMINAL CORONARY ANGIOPLASTY;
TYPES OF STUDY;
URINARY TRACT INFECTION;
VERTIGO;
AGED;
ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY;
ANTIBODIES, MONOCLONAL;
CHI-SQUARE DISTRIBUTION;
COMBINED MODALITY THERAPY;
CORONARY ANGIOGRAPHY;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DOUBLE-BLIND METHOD;
DRUG ADMINISTRATION SCHEDULE;
ELECTROCARDIOGRAPHY;
FEMALE;
FOLLOW-UP STUDIES;
HUMANS;
INFUSIONS, INTRAVENOUS;
MALE;
MIDDLE AGED;
MYOCARDIAL INFARCTION;
NEUROPROTECTIVE AGENTS;
PILOT PROJECTS;
PROBABILITY;
SENSITIVITY AND SPECIFICITY;
SEVERITY OF ILLNESS INDEX;
STATISTICS, NONPARAMETRIC;
SURVIVAL RATE;
TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;
TREATMENT OUTCOME;
|
|
EID: 0035451033
PISSN: 00029149
EISSN: None
Source Type: Journal
DOI: 10.1016/S0002-9149(01)01723-4 Document Type: Article |
|
Times cited : (62)
|
|
References (9)
|
